In a year dominated by onshoring stories, Aragen has seized the advantages of running a biotech business in India.

The milestone is being celebrated as a “huge moment” for rare disease drug development.

Explore the latest news and expert commentary by Fiona Ford, brought to you by the Contributor of BioProcess International.

Explore the latest news and expert commentary by Melissa Nixon, brought to you by the Contributor of BioProcess International ...

Livestock vaccine demand surges but requires specialized animal-vaccine manufacturing workflows with distinct production requirements from human vaccines.

According to the public release, Andelyn Biosciences and the Drake Rayden Foundation will work in partnership with Steven ...

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as next-generation technology.

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP and regulatory landscapes.

The US Food and Drug Administration (FDA) announced the launch of a new framework to expedite therapies for ultra-rare diseases. The program will focus on targeted, individualized treatments for ...

AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for faster life-saving therapies.

Facility commissioning and qualification (C&Q) success begins with project setup meetings that align stakeholders, project metrics, and mitigate risks.